Get the Stockscreener App
0.1608
10.19%
-0.0183
Arch Therapeutics Inc Stock (ARTH) Forecast
The Arch Therapeutics Inc (ARTH) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.0564, representing a -64.89% decrease from the current price of $0.1608. The highest analyst price target is $0.0536, and the lowest is $0.0593.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ARTH Price Target
Average 0.0524
(-67.38% Downside)
Long-term ARTH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Arch Therapeutics Inc financial reports and earnings history, Arch Therapeutics Inc (ARTH) stock could reach $0.1824 by 2030, $0.4801 by 2040 and $0.614 by 2050. See the projected annual prices until 2050 of the Arch Therapeutics Inc stock below:
- Arch Therapeutics Inc (ARTH) is expected to reach an average price of $0.3289 in 2035, with a high prediction of $0.3325 and a low estimate of $0.3361. This indicates an $104.52% rise from the last recorded price of $0.1608.
- Arch Therapeutics Inc (ARTH) stock is projected to chart a bullish course in 2040, with an average price target of $0.4936, representing an $206.99% surge from its current level. The forecast ranges from a conservative $0.4867 to a sky-high $0.4801.
- Our analysts predict Arch Therapeutics Inc (ARTH) to jump 294.97% by 2045, soaring from $0.4719 to an average price of $0.6351, potentially reaching $0.6413. While $0.4719 is the low estimate, the potential upside is significant.
- Arch Therapeutics Inc (ARTH) stock is expected to climb by 2050, reaching an average of $0.6014, a $274.03% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.614 and $0.5888, respectively, highlighting the market's uncertainty.
Arch Therapeutics Inc Stock (ARTH) Year by Year Forecast
Arch Therapeutics Inc Stock (ARTH) Price Forecast for 2025
Arch Therapeutics Inc Stock (ARTH) is expected to reach an average price of $0.0404 in 2025, with a high prediction of $0.0669 and a low estimate of $0.0139. This indicates an -74.86% fall from the last recorded price of $0.1608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.0557 | $0.0593 | $0.0536 | -65.37% |
| June, 2025 | $0.034 | $0.0364 | $0.0528 | -78.83% |
| July, 2025 | $0.0272 | $0.0303 | $0.0281 | -83.07% |
| August, 2025 | $0.0216 | $0.0285 | $0.0185 | -86.57% |
| September, 2025 | $0.0443 | $0.0247 | $0.0449 | -72.44% |
| October, 2025 | $0.0775 | $0.0561 | $0.064 | -51.82% |
| November, 2025 | $0.0676 | $0.0738 | $0.0669 | -57.94% |
| December, 2025 | $0.0422 | $0.0487 | $0.0641 | -73.75% |
Arch Therapeutics Inc Stock (ARTH) Price Forecast for 2026
The predicted value for Arch Therapeutics Inc (ARTH) in 2026 is set at an average of $0.0645. Estimates vary from a peak of $0.0934 to a trough of $0.0355, indicating an -59.90% surge from the present price of $0.1608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0349 | $0.0399 | $0.0367 | -78.32% |
| February, 2026 | $0.0315 | $0.0355 | $0.0288 | -80.39% |
| March, 2026 | $0.0773 | $0.0358 | $0.0641 | -51.94% |
| April, 2026 | $0.0819 | $0.0864 | $0.0802 | -49.06% |
| May, 2026 | $0.0545 | $0.0835 | $0.0787 | -66.13% |
| June, 2026 | $0.0507 | $0.0538 | $0.0525 | -68.50% |
| July, 2026 | $0.0438 | $0.0513 | $0.0413 | -72.76% |
| August, 2026 | $0.0724 | $0.0463 | $0.0733 | -54.97% |
| September, 2026 | $0.1043 | $0.0839 | $0.0908 | -35.12% |
| October, 2026 | $0.0932 | $0.10 | $0.0934 | -42.01% |
| November, 2026 | $0.0663 | $0.0734 | $0.0894 | -58.79% |
| December, 2026 | $0.0577 | $0.0627 | $0.0605 | -64.12% |
Arch Therapeutics Inc Stock (ARTH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Arch Therapeutics Inc (ARTH) is $0.0885, with a high forecast of $0.12 and a low forecast of $0.0571. This indicates an -44.94% decrease from the last price of $0.1608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0531 | $0.0571 | $0.0513 | -66.97% |
| February, 2027 | $0.0934 | $0.0571 | $0.0875 | -41.92% |
| March, 2027 | $0.1081 | $0.1073 | $0.1067 | -32.74% |
| April, 2027 | $0.0794 | $0.1084 | $0.1046 | -50.59% |
| May, 2027 | $0.0741 | $0.0772 | $0.0768 | -53.92% |
| June, 2027 | $0.066 | $0.0741 | $0.0641 | -58.96% |
| July, 2027 | $0.102 | $0.0677 | $0.1017 | -36.57% |
| August, 2027 | $0.1312 | $0.1077 | $0.1177 | -18.42% |
| September, 2027 | $0.1189 | $0.1258 | $0.12 | -26.09% |
| October, 2027 | $0.092 | $0.0981 | $0.1147 | -42.77% |
| November, 2027 | $0.0805 | $0.0855 | $0.0843 | -49.93% |
| December, 2027 | $0.0747 | $0.0787 | $0.0738 | -53.55% |
Arch Therapeutics Inc Stock (ARTH) Price Forecast for 2028
In 2028, Arch Therapeutics Inc (ARTH) is projected to reach an average price of $0.1124, with a high projection of $0.1465 and a low estimate of $0.0784. This indicates an -30.07% fall from the last price of $0.1608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1322 | $0.0784 | $0.1191 | -17.77% |
| February, 2028 | $0.1344 | $0.1394 | $0.1332 | -16.43% |
| March, 2028 | $0.1044 | $0.1334 | $0.1305 | -35.05% |
| April, 2028 | $0.0961 | $0.1025 | $0.1012 | -40.24% |
| May, 2028 | $0.0882 | $0.0969 | $0.0946 | -45.15% |
| June, 2028 | $0.1304 | $0.089 | $0.1301 | -18.91% |
| July, 2028 | $0.158 | $0.1358 | $0.1445 | -1.73% |
| August, 2028 | $0.1445 | $0.1514 | $0.1465 | -10.16% |
| September, 2028 | $0.1164 | $0.1228 | $0.14 | -27.61% |
| October, 2028 | $0.1033 | $0.1083 | $0.1084 | -35.74% |
| November, 2028 | $0.0963 | $0.1003 | $0.0963 | -40.13% |
| December, 2028 | $0.149 | $0.0997 | $0.1443 | -7.36% |
Arch Therapeutics Inc Stock (ARTH) Price Forecast for 2029
The 2029 price forecast for Arch Therapeutics Inc Stock (ARTH) is $0.1483 on average, with a high prediction of $0.1863 and a low estimate of $0.1103. This represents an -7.77% decrease from the previous price of $0.1608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1606 | $0.1623 | $0.1598 | -0.12% |
| February, 2029 | $0.1294 | $0.1584 | $0.1564 | -19.51% |
| March, 2029 | $0.1198 | $0.1262 | $0.1256 | -25.47% |
| April, 2029 | $0.1104 | $0.1193 | $0.1181 | -31.35% |
| May, 2029 | $0.1588 | $0.1103 | $0.1585 | -1.24% |
| June, 2029 | $0.1764 | $0.1639 | $0.1651 | +9.70% |
| July, 2029 | $0.1701 | $0.177 | $0.173 | +5.77% |
| August, 2029 | $0.1408 | $0.1474 | $0.1653 | -12.45% |
| September, 2029 | $0.1309 | $0.1335 | $0.1324 | -18.61% |
| October, 2029 | $0.1178 | $0.1218 | $0.1211 | -26.71% |
| November, 2029 | $0.1767 | $0.1209 | $0.1727 | +9.91% |
| December, 2029 | $0.1868 | $0.1898 | $0.1863 | +16.19% |
Arch Therapeutics Inc Stock (ARTH) Price Forecast for 2030
Arch Therapeutics Inc Stock (ARTH) is expected to reach an average price of $0.1722 in 2030, with a high forecast of $0.2129 and a low forecast of $0.1316. This signifies an +7.09% surge from the last price of $0.1608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.1544 | $0.1834 | $0.1824 | -3.97% |
| February, 2030 | $0.1436 | $0.15 | $0.15 | -10.70% |
| March, 2030 | $0.1336 | $0.1421 | $0.1415 | -16.93% |
| April, 2030 | $0.1872 | $0.1316 | $0.1869 | +16.42% |
| May, 2030 | $0.2036 | $0.192 | $0.1923 | +26.59% |
| June, 2030 | $0.1993 | $0.205 | $0.1996 | +23.92% |
| July, 2030 | $0.1651 | $0.172 | $0.1937 | +2.70% |
| August, 2030 | $0.154 | $0.1566 | $0.1565 | -4.23% |
| September, 2030 | $0.1394 | $0.1434 | $0.144 | -13.29% |
| October, 2030 | $0.2045 | $0.1422 | $0.2011 | +27.19% |
| November, 2030 | $0.2165 | $0.2172 | $0.2129 | +34.61% |
| December, 2030 | $0.1794 | $0.2084 | $0.209 | +11.57% |
0.12%
0.08%
Cap:
|
Volume (24h):